发明名称 New peptide derivatives used as urokinase inhibitors for therapy, prophylaxis or diagnosis of tumors, especially for reducing tumor metastasis
摘要 Peptide derivatives (I) are new. Peptide derivatives of formula R5-A-NH-Y(R1)-V'-U'-Z (I) and their prodrugs and salts are new. A = P2-P1; P1 = a group of formula N(R3)-X(R2)-CO; P2 = a group of formula (i); R1 = H or (CH2)aCOOR6; a = 0-5; R6 = 1-6C alkyl; R2 = H, 1-8C alkyl, (CH2)cCOOR8, (CH2)dOH, (CH2)eQ or (CH2)kOCOOR16; c, d = 1-4; R8 = H or 1-6C alkyl; Q = R10, OR10, SR10, guanidino, imidazolyl or NHR10; e = 1-5; R10 = H, 1-16C alkyl or aryl, heteroaryl, aralkyl or heteroaralkyl (all optionally substituted); k = 1-8; R16 = 1-16C alkyl, or aryl, heteroaryl, aralkyl or heteroaralkyl (all optionally substituted), adamantyl, camphor or cyclohexylmethyl; R3 = (CH2)bR7; b = 1-8; R7 = H, 1-10C alkyl or a charged group; R4 = 1-8C alkyl, (CH2)fOR11, (CH2)fSR11 or (CH2)fNHR11; f = 1-8; R11 = H or COOR17; R17 = 1-16C alkyl, or aryl, heteroaryl, aralkyl or heteroaralkyl (all optionally substituted), adamantyl, camphor or cyclohexylmethyl; R5 = (CH2)g(CH3)h, (CH2)i-aryl, SO2R12, COR12 or COOR12, all optionally modified with a charged or uncharged group; i = 0-3; g + h = 0-3; R12 = 1-16C alkyl, or aryl, heteroaryl, aralkyl or heteroaralkyl (all optionally substituted), adamantyl, camphor or cyclohexylmethyl; U' = phenyl, cyclohexyl, heterophenyl or heterocyclohexyl; V' = (CH2)n; n = 0-3; X = N or CH; Y = N or (CH)m; m = 0 or 1; Z = aminomethyl, guanidino or C(NH)NHR14 in the 3 or 4 position; R14 = H, OH, NH2, COR15 or COOR15, and R15 = 1-16C alkyl or aryl, heteroaryl, aralkyl or heteroaralkyl (all optionally substituted), provided that at least one charged group is in R1, R2, R3 or R5. An Independent claim is also included for preparation of (I).
申请公布号 DE10210592(A1) 申请公布日期 2003.10.02
申请号 DE20021010592 申请日期 2002.03.11
申请人 CURACYTE AG 发明人 STUERZEBECHER, JOERG;STEINMETZER, TORSTEN;SCHWEINITZ, ANDREA
分类号 A61K38/00;C07K5/02;C07K5/06;C07K7/06;(IPC1-7):C07K5/06;A61K38/05 主分类号 A61K38/00
代理机构 代理人
主权项
地址